secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001493152-25-020815
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical launches limited U.S. commercial release of LIBERTY robotic system
--------------------------------------------------------------------------------

- LIBERTY Endovascular Robotic System now commercially available in U.S. on a limited basis after FDA 510(k) clearance in September 2025.
- Limited Market Release (LMR) targets high procedure volume regions with existing preliminary demand; Full Market Release (FMR) planned for April 2026 at Society of Interventional Radiology meeting.
- Company has hired core commercial team and secured third-party logistics partner to support the launch.
- CEO Harel Gadot states the launch marks entry into commercialization phase, building a new robotic category with single-use system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315225020815/0001493152-25-020815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315225020815/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer